A randomised, placebo-controlled, double-blind study of aprepitant in nondrinking women younger than 70 years receiving moderately emetogenic chemotherapy

被引：0
作者：
M Tanioka
A Kitao
K Matsumoto
N Shibata
S Yamaguchi
K Fujiwara
H Minami
N Katakami
S Morita
S Negoro
机构：
[1] Medical Oncology,Department of Pharmacy
[2] Hyogo Cancer Center,Division of Pulmonary Medicine
[3] Medical Oncology/Hematology,undefined
[4] Kobe University Graduate School of Medicine,undefined
[5] Hyogo Cancer Center,undefined
[6] Gynecologic Oncology,undefined
[7] Hyogo Cancer Center,undefined
[8] Kobe City Medical Center General Hospital,undefined
来源：
British Journal of Cancer | 2013年 / 109卷
关键词：
aprepitant; moderately emetogenic chemotherapy; carboplatin; female; alcohol use;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：859 / 865
页数：6
相关论文
共 50 条
  • [31] Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase III trial
    Zhihuang Hu
    Ying Cheng
    Hongyu Zhang
    Caicun Zhou
    Baohui Han
    Yiping Zhang
    Cheng Huang
    Jianhua Chang
    Xiangqun Song
    Jun Liang
    Houjie Liang
    Chunxue Bai
    Shiying Yu
    Jia Chen
    Jie Wang
    Hongming Pan
    Denesh K. Chitkara
    Darcy A. Hille
    Li Zhang
    Supportive Care in Cancer, 2014, 22 : 979 - 987
  • [32] A randomized, double-blind, placebo-controlled, dose ranging study to assess the efficacy and safety of eltrombopag in patients receiving carboplatin/paclitaxel for advanced solid tumors
    Kellum, A.
    Jagiello-Gruszfeld, A.
    Bondarenko, I. N.
    Patwardhan, R.
    Messam, C.
    Kamel, Y. Mostafa
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (10) : 2339 - 2346
  • [33] Intravenous fosaprepitant for the prevention of chemotherapy-induced vomiting in children: A double-blind, placebo-controlled, phase III randomized trial
    Radhakrishnan, Venkatraman
    Joshi, Archit
    Ramamoorthy, Jaikumar
    Rajaraman, Swaminathan
    Ganesan, Prasanth
    Ganesan, Trivadi S.
    Dhanushkodi, Manikandan
    Sagar, Tenali G.
    PEDIATRIC BLOOD & CANCER, 2019, 66 (03)
  • [34] Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial
    Krug, Lee M.
    Kindler, Hedy L.
    Calvert, Hilary
    Manegold, Christian
    Tsao, Anne S.
    Fennell, Dean
    Ohman, Ronny
    Plummer, Ruth
    Eberhardt, Wilfried E. E.
    Fukuoka, Kazuya
    Gaafar, Rabab M.
    Lafitte, Jean-Jacques
    Hillerdal, Gunnar
    Chu, Quincy
    Buikhuisen, Wieneke A.
    Lubiniecki, Gregory M.
    Sun, Xing
    Smith, Margaret
    Baas, Paul
    LANCET ONCOLOGY, 2015, 16 (04) : 447 - 456
  • [35] Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting - Results from a randomized, double-blind, placebo-controlled trial in Latin America
    Poli-Bigelli, S
    Rodrigues-Pereira, J
    Carides, AD
    Ma, GGJ
    Eldridge, K
    Hipple, A
    Evans, JK
    Horgan, KJ
    Lawson, F
    CANCER, 2003, 97 (12) : 3090 - 3098
  • [36] Pilot Study of Aprepitant for Prevention of Post-ERCP Pancreatitis in High Risk Patients: A Phase II Randomized, Double-Blind Placebo Controlled Trial
    Shah, Tilak Upendra
    Liddle, Rodger
    Branch, M. Stanley
    Jowell, Paul
    Obando, Jorge
    Poleski, Martin
    JOURNAL OF THE PANCREAS, 2012, 13 (05): : 514 - 518
  • [37] Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive-stage small cell lung cancer: A multicentre, randomised, double-blind, placebo-controlled Phase II trial
    Daniel, Davey
    Kuchava, Vladimer
    Bondarenko, Igor
    Ivashchuk, Oleksandr
    Reddy, Sreekanth
    Jaal, Jana
    Kudaba, Iveta
    Hart, Lowell
    Matitashvili, Amiran
    Pritchett, Yili
    Morris, Shannon R.
    Sorrentino, Jessica A.
    Antal, Joyce M.
    Goldschmidt, Jerome
    INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (10) : 2557 - 2570
  • [38] Single-dose Tadalafil Reduces Opening Urethral Pressure: A Randomized, Double-blind, Placebo-controlled, Crossover Trial in Healthy Women
    Christoffersen, Thea
    Riis, Troels
    Sonne, David P.
    Klarskov, Niels
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2024, 35 (03) : 723 - 729
  • [39] Effect of a Standardized Ginger Root Powder Regimen on Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial
    Crichton, Megan
    Marshall, Skye
    Isenring, Elizabeth
    Lohning, Anna
    Mccarthy, Alexandra L.
    Molassiotis, Alex
    Bird, Robert
    Shannon, Catherine
    Koh, Andy
    Mcpherson, Ian
    Marx, Wolfgang
    JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS, 2024, 124 (03) : 313 - 330.e6
  • [40] Single-dose Tadalafil Reduces Opening Urethral Pressure: A Randomized, Double-blind, Placebo-controlled, Crossover Trial in Healthy Women
    Thea Christoffersen
    Troels Riis
    David P. Sonne
    Niels Klarskov
    International Urogynecology Journal, 2024, 35 : 723 - 729
12345